Deloitte buys data warehouse firm

| October 30, 2012 | Health Exec | Economics

Deloitte Consulting Services has acquired Recombinant Data, a developer of data warehousing and clinical intelligence systems for personalized medicine, translational research and healthcare performance management. Terms of the acquisition were not disclosed.

Based in Newton, Mass., Recombinant, founded in 2005, seeks to relate to enterprise data integration, population health analytics, clinical genome data assimilation and performance management for accountable care organizations. According to Deloitte, Recombinant also seeks to assist academic medical centers, federal agencies and life sciences companies conduct translational research and analyze phenomic, genomic and bio-banking data in pursing personalized and evidence-based medicine.

Recombinant’s business will reside within Deloitte Consulting Innovation under the name “Recombinant By Deloitte.”

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Deloitte buys data warehouse firm

Related Content

Around the web